Hansheng Xue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hansheng Xue has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Aishwarya Jayagopal
Cancer Science Cancer Science Pitt Cancer Science Cancer Science National University of Singapore Singapore National University of Singapore Singapore National University of Singapore Singapore National University Cancer Institute Singapore National University of Singapore Singapore Institute of Singapore Singapore Institute of Singapore Singapore Institute of Singapore Singapore Institute of Singapore Singapore National University of Singapore Singapore
1 shared publication - Anand Devaprasath Jeyasekharan
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
1 shared publication - David Shao Peng Tan
Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
1 shared publication Guannan Zhang
1 shared publication- Jason J. Pitt
Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
1 shared publication - Jianxing Ma1 shared publication
Latest Publications
- Open Access
Modeling User Intent Beyond Trigger: Incorporating Uncertainty for Trigger-Induced Recommendation
To cater to users' desire for an immersive browsing experience, numerous e-commerce platforms provide various recommendation scenarios, with a focus on Trigger-Induced Recommendation (TIR) tasks. However, the majority of current TIR methods heavily rely on the trigger item to understand user intent, lacking a higher-level exploration and exploitation of user intent (e.g., popular items and complementary items), which may result in an overly convergent understanding of users' short-term intent and can be detrimental to users' long-term purchasing experiences. Moreover, users' short-term intent shows uncertainty and is affected by various factors such as browsing context and historical behaviors, which poses challenges to user intent modeling. To address these challenges, we propose a novel model called Deep Uncertainty Intent Network (DUIN), comprising three essential modules: i) Explicit Intent Exploit Module extracting explicit user intent using the contrastive learning paradigm; ii) Latent Intent Explore Module exploring latent user intent by leveraging the multi-view relationships between items; iii) Intent Uncertainty Measurement Module offering a distributional estimation and capturing the uncertainty associated with user intent. Experiments on three real-world datasets demonstrate the superior performance of DUIN compared to existing baselines. Notably, DUIN has been deployed across all TIR scenarios in our e-commerce platform, with online A/B testing results conclusively validating its superiority.
Open AccessModeling User Intent Beyond Trigger: Incorporating Uncertainty for Trigger-Induced Recommendation
To cater to users' desire for an immersive browsing experience, numerous e-commerce platforms provide various recommendation scenarios, with a focus on Trigger-Induced Recommendation (TIR) tasks. However, the majority of current TIR methods heavily rely on the trigger item to understand user intent, lacking a higher-level exploration and exploitation of user intent (e.g., popular items and complementary items), which may result in an overly convergent understanding of users' short-term intent and can be detrimental to users' long-term purchasing experiences. Moreover, users' short-term intent shows uncertainty and is affected by various factors such as browsing context and historical behaviors, which poses challenges to user intent modeling. To address these challenges, we propose a novel model called Deep Uncertainty Intent Network (DUIN), comprising three essential modules: i) Explicit Intent Exploit Module extracting explicit user intent using the contrastive learning paradigm; ii) Latent Intent Explore Module exploring latent user intent by leveraging the multi-view relationships between items; iii) Intent Uncertainty Measurement Module offering a distributional estimation and capturing the uncertainty associated with user intent. Experiments on three real-world datasets demonstrate the superior performance of DUIN compared to existing baselines. Notably, DUIN has been deployed across all TIR scenarios in our e-commerce platform, with online A/B testing results conclusively validating its superiority.
- Open Access
Personalised Drug Identifier for Cancer Treatment with Transformers using Auxiliary Information
Cancer remains a global challenge due to its growing clinical and economic burden. Its uniquely personal manifestation, which makes treatment difficult, has fuelled the quest for personalized treatment strategies. Thus, genomic profiling is increasingly becoming part of clinical diagnostic panels. Effective use of such panels requires accurate drug response prediction (DRP) models, which are challenging to build due to limited labelled patient data. Previous methods to address this problem have used various forms of transfer learning. However, they do not explicitly model the variable length sequential structure of the list of mutations in such diagnostic panels. Further, they do not utilize auxiliary information (like patient survival) for model training. We address these limitations through a novel transformer based method, which surpasses the performance of state-of-the-art DRP models on benchmark data. We also present the design of a treatment recommendation system (TRS), which is currently deployed at the National University Hospital, Singapore and is being evaluated in a clinical trial.
Open AccessPersonalised Drug Identifier for Cancer Treatment with Transformers using Auxiliary Information
Cancer remains a global challenge due to its growing clinical and economic burden. Its uniquely personal manifestation, which makes treatment difficult, has fuelled the quest for personalized treatment strategies. Thus, genomic profiling is increasingly becoming part of clinical diagnostic panels. Effective use of such panels requires accurate drug response prediction (DRP) models, which are challenging to build due to limited labelled patient data. Previous methods to address this problem have used various forms of transfer learning. However, they do not explicitly model the variable length sequential structure of the list of mutations in such diagnostic panels. Further, they do not utilize auxiliary information (like patient survival) for model training. We address these limitations through a novel transformer based method, which surpasses the performance of state-of-the-art DRP models on benchmark data. We also present the design of a treatment recommendation system (TRS), which is currently deployed at the National University Hospital, Singapore and is being evaluated in a clinical trial.